Jinling Pharmaceutical Company Limited (SHE:000919)

China flag China · Delayed Price · Currency is CNY
7.39
+0.07 (0.96%)
Apr 30, 2026, 3:04 PM CST
14.57%
Market Cap 4.55B
Revenue (ttm) 3.16B
Net Income (ttm) 58.94M
Shares Out 621.92M
EPS (ttm) 0.09
PE Ratio 77.27
Forward PE n/a
Dividend 0.10 (1.37%)
Ex-Dividend Date Jul 8, 2025
Volume 23,959,500
Average Volume 65,651,431
Open 7.36
Previous Close 7.32
Day's Range 7.25 - 7.44
52-Week Range 6.41 - 9.80
Beta 0.43
RSI 46.39
Earnings Date Aug 24, 2026

About SHE:000919

Jinling Pharmaceutical Company Limited, together with its subsidiaries, manufactures and sells pharmaceuticals and medical devices in China and internationally. It offers Mailuoning injection and oral solution for the treatment of thromboangiitis and arteriosclerosis obliterans, as well as cerebral and venous thrombosis; Sulifei, a ferrous succinate tablet for the prevention and treatment of iron deficiency anemia; Lentinan injection, an adjuvant therapy for the treatment of malignant tumors; and absorbable gelatin sponges for the treatment of ... [Read more]

Sector Healthcare
Founded 1998
Employees 5,789
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000919
Full Company Profile

Financial Performance

In 2025, SHE:000919's revenue was 3.20 billion, a decrease of -2.56% compared to the previous year's 3.28 billion. Earnings were 53.91 million, an increase of 33.42%.

Financial Statements

News

There is no news available yet.